Pioglitazone Hydrochloride and Metformin Hydrochloride
- Product NDC
- 0378-1575
- 11-digit product format
- 003781575
- Labeler code
- 0378
- Product ID
- 0378-1575_4229b266-ce42-45af-b41b-0426f025179b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- pioglitazone hydrochloride and metformin hydrochloride
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Mylan Pharmaceuticals Inc.
- Application
- ANDA090406
- Marketing category
- ANDA
- Marketing start
- 2012-08-17
- Marketing end
- 2019-06-30
- Substance
- PIOGLITAZONE HYDROCHLORIDE; METFORMIN HYDROCHLORIDE
- Active strength
- 15 mg/1; mg/1
- Pharmacologic classes
- Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR alpha [CS],PPAR gamma [CS],Thiazolidinedione [EPC],Thiazolidinediones [CS],Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator Receptor gamma Agonist [EPC],Biguanide [EPC],Biguanides [CS]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record